Teprotumumab for treating thyroid eye disease [ID6432]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Eneboparatide for treating chronic hypoparathyroidism [ID6532]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC